Literature DB >> 17029785

V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation.

Stéphanie Chasseigneaux1, Stéphane Haïk, Isabelle Laffont-Proust, Olivier De Marco, Martine Lenne, Jean-Philippe Brandel, Jean-Jacques Hauw, Jean-Louis Laplanche, Katell Peoc'h.   

Abstract

A valine to isoleucine mutation at residue 180 was identified in a French patient with Creutzfeldt-Jakob disease (CJD). The mutation is located in the close vicinity of one of the two N-glycosylation sites of the cellular prion protein (PrP(C)). Western blot analysis revealed accumulation in the brain of the pathogenic proteinase K-resistant PrP (PrP(Sc)) isoform with the notable absence of the diglycosylated band. The mutant protein expressed in CHO cells was correctly glycosylated, suggesting that the atypical glycosylation pattern of PrP(Sc) was not due to the mutation at position 180. These results suggest that the diglycosylated form of the mutant PrP(180I) prevents its conversion into the pathogenic mutant form PrP(Sc180I), supporting a central role of N-linked glycan chains in the PrP conversion process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029785     DOI: 10.1016/j.neulet.2006.08.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

Authors:  Alejandro M Sevillano; Patricia Aguilar-Calvo; Timothy D Kurt; Jessica A Lawrence; Katrin Soldau; Thu H Nam; Taylor Schumann; Donald P Pizzo; Sofie Nyström; Biswa Choudhury; Hermann Altmeppen; Jeffrey D Esko; Markus Glatzel; K Peter R Nilsson; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 3.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  A novel phenotype of sporadic Creutzfeldt-Jakob disease.

Authors:  G Giaccone; Giuseppe Di Fede; Michela Mangieri; Lucia Limido; Raffaella Capobianco; Silvia Suardi; Marina Grisoli; Simona Binelli; Paolo Fociani; Orso Bugiani; Fabrizio Tagliavini
Journal:  BMJ Case Rep       Date:  2009-02-02

5.  Rare V180I mutation in PRNP gene of a Chinese patient with Creutzfeldt-Jakob disease.

Authors:  Qi Shi; Xiao-Jing Shen; Wei Zhou; Kang Xiao; Xiao-Mei Zhang; Bao-Yun Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2014       Impact factor: 3.931

6.  A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.

Authors:  E Tunnell; R Wollman; S Mallik; C J Cortes; S J Dearmond; J A Mastrianni
Journal:  Neurology       Date:  2008-10-28       Impact factor: 9.910

Review 7.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

8.  Familial Creutzfeldt-Jakob disease with a V180I mutation: comparative analysis with pathological findings and diffusion-weighted images.

Authors:  Kazuo Mutsukura; Katsuya Satoh; Susumu Shirabe; Itsuro Tomita; Takayasu Fukutome; Minoru Morikawa; Masachika Iseki; Kensuke Sasaki; Yusei Shiaga; Tetsuyuki Kitamoto; Katsumi Eguchi
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-30       Impact factor: 2.959

9.  Familial Creutzfeldt-Jakob disease with V180I mutation.

Authors:  Tae-Il Yang; Dae-Soo Jung; Bo-Young Ahn; Byung-Hoon Jeong; Han-Jeong Cho; Yong-Sun Kim; Duk L Na; Michael D Geschwind; Eun-Joo Kim
Journal:  J Korean Med Sci       Date:  2010-06-16       Impact factor: 2.153

10.  A novel phenotype of sporadic Creutzfeldt-Jakob disease.

Authors:  G Giaccone; G Di Fede; M Mangieri; L Limido; R Capobianco; S Suardi; M Grisoli; S Binelli; P Fociani; O Bugiani; F Tagliavini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.